A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the safety, tolerability, and pharmacokinetics (PK) of a single
oral dose of surotomycin (CB-183,315) at ascending dose levels when given to healthy males
and females.